HealthStream, Inc. (NASDAQ:HSTM) Shares Sold by Segall Bryant & Hamill LLC

Segall Bryant & Hamill LLC cut its holdings in shares of HealthStream, Inc. (NASDAQ:HSTMFree Report) by 12.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 110,007 shares of the technology company’s stock after selling 15,157 shares during the period. Segall Bryant & Hamill LLC owned approximately 0.36% of HealthStream worth $3,498,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in HSTM. Barclays PLC lifted its position in shares of HealthStream by 145.0% during the 3rd quarter. Barclays PLC now owns 58,838 shares of the technology company’s stock valued at $1,697,000 after acquiring an additional 34,821 shares during the last quarter. Robeco Institutional Asset Management B.V. raised its position in shares of HealthStream by 26.9% during the fourth quarter. Robeco Institutional Asset Management B.V. now owns 76,260 shares of the technology company’s stock worth $2,425,000 after purchasing an additional 16,166 shares during the period. State Street Corp boosted its position in shares of HealthStream by 1.2% in the 3rd quarter. State Street Corp now owns 974,235 shares of the technology company’s stock valued at $28,097,000 after purchasing an additional 11,976 shares during the period. JPMorgan Chase & Co. increased its stake in HealthStream by 18.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 57,204 shares of the technology company’s stock worth $1,650,000 after purchasing an additional 9,017 shares in the last quarter. Finally, FMR LLC raised its holdings in HealthStream by 24.0% during the 3rd quarter. FMR LLC now owns 119,067 shares of the technology company’s stock worth $3,434,000 after buying an additional 23,055 shares during the period. 69.58% of the stock is currently owned by institutional investors.

HealthStream Price Performance

NASDAQ HSTM opened at $32.09 on Friday. The firm has a market capitalization of $976.63 million, a price-to-earnings ratio of 49.37, a price-to-earnings-growth ratio of 4.37 and a beta of 0.37. The company has a 50 day simple moving average of $32.59 and a 200-day simple moving average of $31.31. HealthStream, Inc. has a 52-week low of $23.92 and a 52-week high of $34.24.

HealthStream (NASDAQ:HSTMGet Free Report) last released its quarterly earnings data on Monday, February 24th. The technology company reported $0.16 earnings per share for the quarter, beating the consensus estimate of $0.13 by $0.03. The firm had revenue of $74.24 million for the quarter, compared to analyst estimates of $73.55 million. HealthStream had a net margin of 6.84% and a return on equity of 5.67%. During the same quarter in the prior year, the business earned $0.14 EPS. On average, analysts predict that HealthStream, Inc. will post 0.63 EPS for the current year.

HealthStream Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 21st. Investors of record on Monday, March 10th were issued a dividend of $0.031 per share. This represents a $0.12 annualized dividend and a dividend yield of 0.39%. This is a positive change from HealthStream’s previous quarterly dividend of $0.03. The ex-dividend date of this dividend was Monday, March 10th. HealthStream’s dividend payout ratio (DPR) is currently 18.18%.

Wall Street Analyst Weigh In

HSTM has been the subject of several recent analyst reports. JMP Securities reiterated a “market perform” rating on shares of HealthStream in a report on Thursday, February 6th. Canaccord Genuity Group raised their price objective on shares of HealthStream from $29.00 to $30.00 and gave the stock a “hold” rating in a research note on Wednesday, February 26th. Finally, William Blair reissued an “outperform” rating on shares of HealthStream in a research note on Tuesday, February 25th. Two investment analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $32.00.

Read Our Latest Stock Analysis on HSTM

HealthStream Profile

(Free Report)

HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company’s solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.

Featured Stories

Institutional Ownership by Quarter for HealthStream (NASDAQ:HSTM)

Receive News & Ratings for HealthStream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream and related companies with MarketBeat.com's FREE daily email newsletter.